Foldax, Inc had developed Tria™ heart valves made with a revolutionary new LifePolymer™ material and designed to last a lifetime. The goal is to help millions of patients worldwide with aortic, mitral, and tricuspid valve disease receive cost-effective treatment in a single heart valve procedure. A TAVR platform is in development. Driven by a passion to help patients, we collaborate with leading clinicians and researchers to design and manufacture heart valves intended to provide sustainable quality of life improvement for people with aortic, mitral or tricuspid valve disease.
Website: https://foldax.com